Clinical Trials for 3D Medicines

Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC

Study of 3D189 in Patients With Hematologic Malignancies

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

A Monotherapy in Subjects With Advanced Solid Tumors

KN035 for dMMR/MSI-H Advanced Solid Tumors

Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC